Condition

Immune System Diseases

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 36 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials36

Recruiting6

Common interventions25

Lead sponsors shown15

Clinical trials

36 shown

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)NCT07699380 · 2026-09-01

Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility StudyNCT07759115 · 2026-08-10

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusNCT06575426 · 2025-06-10

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult CareNCT05910840 · 2024-10-07

Implementation of Support in the Care of Adults Living With Type 1 DiabetesNCT06069583 · 2024-05-05

Activation and Function of Eosinophils in Conditions With Blood or Tissue EosinophiliaNCT00001406 · 1997-04-21

IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple SclerosisNCT06677710 · 2026-06-30

Digital Diagnostics and Intervention Services for Parkinson's DiseaseNCT06534177 · 2024-10-15

HIV Engagement and Adolescent Depression Support (HEADS-UP)NCT06173544 · 2024-07-06

Individualizing Treatment for Asthma in Primary CareNCT06272370 · 2024-02-01

Group Education Trial to Improve Transition for Parents of Adolescents With T1DNCT05445284 · 2023-10-10

Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility StudyNCT05792176 · 2023-03-27

Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in ChinaNCT05726461 · 2023-02-11

An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1DNCT05565248 · 2023-01-20

A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid ArthritisNCT05516758 · 2022-08-31

Friendship Bench Adaptation to Improve Mental Health & HIV Care Engagement Outcomes Among PLWH and PWID in VietnamNCT04790201 · 2022-02-28

An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1DNCT05210530 · 2022-01-24

Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or NatalizumabNCT04837651 · 2021-03-02

Anti-viral Effects of Azithromycin in Patients With Asthma and COPDNCT04319705 · 2020-03-02

Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and PolymorphismsNCT06065592 · 2019-02-01

No-worry Baby ProjectNCT03922087 · 2018-11-20

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)NCT03688074 · 2018-11-02

Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With OcrevusNCT03562975 · 2018-07-23

Investigating Genetic Risk for Type 1 DiabetesNCT03503747 · 2018-04-25

Mechanism of Action of Ocrelizumab in Multiple SclerosisNCT03344094 · 2018-02-23

Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 DiabetesNCT03345004 · 2017-12-20

Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid ArthritisNCT03337165 · 2016-12-01

Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 DiabetesNCT03199638 · 2016-04-01

Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes MellitusNCT02644759 · 2014-02-01

Pharmacokinetics Study of Gamma-aminobutyric AcidNCT01917760 · 2013-07-01

Asthma Data Innovation Demonstration ProjectNCT02162576 · 2012-06-01

Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in KenyaNCT01425073 · 2012-02-01

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima PeruNCT02630082 · 2011-04-01

Mesalamine to Reduce T Cell Activation in HIV InfectionNCT01090102 · 2010-06-01

Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple SclerosisNCT01056471 · 2010-01-01

Improving HIV Screening With Nurse-Based Rapid Testing/Streamlined CounselingNCT00119548 · 2005-03-01

Common interventions

Leading sponsors

CRISPR Therapeutics AG 2 National Institute of Allergy and Infectious Diseases (NIAID) 2 University of North Carolina, Chapel Hill 2 University of Texas at Austin 2 University of Washington 2 Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 1 Anne-Sophie Brazeau 1 AstraZeneca 1 Bispebjerg Hospital 1 DARTNet Institute 1 David Van Sickle 1 Diamyd Medical AB 1 Dragonfly Research, LLC 1 Eli Lilly and Company 1 Huashan Hospital 1

Trial status mix

COMPLETED23

RECRUITING6

UNKNOWN4

TERMINATED2

SUSPENDED1

Phase mix

NA13

PHASE18

PHASE27

PHASE43

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.